GLP-1 in pregnancy

What is GLP-1 in pregnancy?

Every approved GLP-1 carries a pregnancy precaution, with discontinuation recommended at least two months ahead of a planned conception for semaglutide given its half-life.

Animal studies show developmental toxicity at human-equivalent doses; there are no randomized human data and observational registries are still accumulating. Reliable contraception matters for anyone of reproductive age. Accidental early exposure is not in itself an indication for termination; that is a conversation for a maternal-fetal medicine specialist.

Wegovy cheat sheet (red flags) →

GLP Watchdog writes these definitions from FDA labels and peer-reviewed PubMed literature.

Where GLP-1 in pregnancy comes up on this site

Other terms under Patient experience

• Plateau
• Microdosing
• Switching GLP-1s
• Rebound weight gain
• GLP-1 + anesthesia (preoperative)
• Subcutaneous (subq) injection
• Intensive Behavioral Therapy (IBT)

Where the evidence lives

• The full GLP-1 glossary (150 terms, 8 categories)
• Research articles — written from primary sources
• Tools and calculators
• Compare GLP-1 telehealth providers